Found 924 articles for: "acne"
FULL SUPPLEMENT: Updating Antibiotic Use for Acne Management in 2023
February 2024 | Volume 23 | Issue 2 | Department | SF378969s1 | Copyright © February 2024
Antibiotics, topical and oral, are a cornerstone in the treatment of acnes vulgaris specifically by targeting the skin bacterium Cutibacterium acnes. Billions of individuals have received antibio...
Read MoreINDIVIDUAL ARTICLE: Vehicles Matter!
February 2024 | Volume 23 | Issue 2 | Supplement Individual Articles | SF378969s3 | Copyright © February 2024
INDIVIDUAL ARTICLE: Sarecycline Improves Acne Severity, Symptoms, and Psychosocial Burden in Non-nodular Acne Vulgaris: PROSES Study
February 2024 | Volume 23 | Issue 2 | Supplement Individual Articles | SF405634s12 | Copyright © February 2024
Background: Patient-reported outcomes (PROs) are emerging as a fundamental component of disease impact assessment in acne vulgaris (AV), complementing clinician-reported outcomes...
Read MoreINDIVIDUAL ARTICLE: Impact of Acne Vulgaris and Sarecycline on Social/Emotional Functioning and Daily Activities: PROSES Study
February 2024 | Volume 23 | Issue 2 | Supplement Individual Articles | SF405634s5 | Copyright © February 2024
Background: Concise patient-reported outcome (PRO) instruments addressing the consequences of facial acne vulgaris (AV) on patients’ functioning and activities of daily liv...
Read MoreINDIVIDUAL ARTICLE: Assessing the Impact of Acne and Its Treatment on Disease Burden and Quality of Life
February 2024 | Volume 23 | Issue 2 | Supplement Individual Articles | SF405634s4 | Copyright © February 2024
Benefit of Topical Combination Therapy for Acne: Analyzing Effect Size Using Number Needed to Treat
February 2024 | Volume 23 | Issue 2 | Original Article | 42 | Copyright © February 2024
Background: Topical acne trials often are confounded by high vehicle response rates and differing outcome measures, making it difficult to compare treatments. Number needed to tr...
Read MoreNew Insights Into Systemic Drivers of Inflammation and Their Contributions to the Pathophysiology of Acne
February 2024 | Volume 23 | Issue 2 | Original Article | 90 | Copyright © February 2024
Read MoreOutcomes for Psoriasis by Self-Identified Racial Groups in Ixekizumab Clinical Trials: A Pooled Analysis
February 2024 | Volume 23 | Issue 2 | Original Article | 17 | Copyright © February 2024
Background: Biologics have shown promising outcomes in psoriasis clinical trials. However, there is a paucity of data exploring the potential differences in outcomes between self...
Read MoreA New Tool to Improve Communication Between Hidradenitis Suppurativa Patients and Health Care Providers
February 2024 | Volume 23 | Issue 2 | Features | 105 | Copyright © February 2024
Background: Hidradenitis suppurativa (HS) patients tend to experience diagnosis delay, misdiagnosis, and embarrassment due to their condition. To address these issues, the Intern...
Read MoreCysteamine Isobionic-Amide Complex Versus Kligman's Formula for the Treatment of Melasma: Equal Efficacy and Rapid Onset of Action
February 2024 | Volume 23 | Issue 2 | Original Article | 9 | Copyright © February 2024
Background: Modified Kligman's formula (mKF) is the gold standard treatment for melasma; however, its prolonged use is not recommended due to side effects. Cysteamine is a potent...
Read MoreTargeting the Aryl Hydrocarbon Receptor to Address the Challenges of Atopic Dermatitis
February 2024 | Volume 23 | Issue 2 | Original Article | 23 | Copyright © February 2024
Atopic dermatitis (AD) is a chronic relapsing–remitting disease with a multifactorial etiology involving epidermal barrier and immunologic dysfunction. Topical therapies form the mainstay o...
Read MoreSarecycline as a Potential Treatment for Steroid-Induced Rosacea/Perioral Dermatitis: A Case Report
February 2024 | Volume 23 | Issue 2 | Case Reports | e55 | Copyright © February 2024
Applications of Bioactive Peptides in Dermatology
January 2024 | Volume 23 | Issue 1 | Features | 1369 | Copyright © January 2024
Objective Facial Assessment With Artificial Intelligence: Introducing the Facial Aesthetic Index and Facial Youthfulness Index
January 2024 | Volume 23 | Issue 1 | Editorials | e52 | Copyright © January 2024
Incorporating a Prognostic Gene Expression Profile Test into the Management of Cutaneous Squamous Cell Carcinoma: An Expert Consensus Panel Report
February 2024 | Volume 23 | Issue 2 | Original Article | 54 | Copyright © February 2024
Background: Cutaneous squamous cell carcinoma (cSCC) is a growing health concern with a rapidly increasing incidence. Disease-specific mortality is typically preceded by a m...
Read MoreRevolutionizing Neck Rejuvenation: ABO Botulinum Toxin A Solution in Multipoint Technique and NASHA Gel Skinbooster
January 2024 | Volume 23 | Issue 1 | Original Article | 1344 | Copyright © January 2024
Background: Neck rejuvenation is an increasingly sought-after cosmetic procedure that offers a versatile solution to address various aging-related concerns in the neck area. Beca...
Read MoreCurrent Landscape of Hyaluronic Acid Filler Use in the United States
January 2024 | Volume 23 | Issue 1 | Original Article | 1247 | Copyright © January 2024
Background: Hyaluronic acid (HA) fillers are among the most used fillers for soft-tissue augmentation. There are now many FDA-approved HA products, and the successful use of inje...
Read MoreInternational Consensus on Anti-Aging Dermocosmetics and Skin Care for Clinical Practice Using the RAND/UCLA Appropriateness Method
January 2024 | Volume 23 | Issue 1 | Original Article | 1337 | Copyright © January 2024
Background: The objective was to provide international recommendations on anti-aging dermocosmetics for clinical practice starting with essential ingredients for protection and r...
Read MoreIntegrated Short-Term and Long-Term Efficacy of Topical Clascoterone Cream 1% in Patients Aged 12 Years or Older With Acne Vulgaris
January 2024 | Volume 23 | Issue 1 | Original Article | 1278 | Copyright © January 2024
Background: Clascoterone cream 1% is approved for the treatment of acne vulgaris in patients aged 12 years or older based on results from two identical pivotal Phase 3 trials. In...
Read MoreThe 200-Year Timeline on Botulinum Toxin: From Biologic Poison to Wonder Drug
January 2024 | Volume 23 | Issue 1 | Features | 1357 | Copyright © January 2024
Media and other results for: "acne"